v3.26.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series D Convertible Preferred Stock
Preferred Stock
Series E Convertible Preferred Stock
Preferred Stock
Series D Preferred Stock and warrants
Common Stock
Additional Paid-In Capital
Series C Convertible Preferred Stock
Additional Paid-In Capital
Series D Preferred Stock and warrants
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Series E Convertible Preferred Stock
Series D Preferred Stock and warrants
Total
Beginning balance at Dec. 31, 2024 $ 912,830                            
Beginning balance (in shares) at Dec. 31, 2024 4,285                            
Temporary Equity                              
Preferred stock dividends paid $ 80,363 $ 16,806                          
Issuance of preferred stock and warrants (in shares)       5,500                      
Deemed dividends on preferred stock 106,973               $ (106,973)           $ (106,973)
Preferred stock accretion   324,795                          
Preferred stock dividends                 (97,169)           (97,169)
Ending balance at Jun. 30, 2025 $ 267,711 $ 446,942                          
Ending balance (in shares) at Jun. 30, 2025 223 5,500                          
Beginning balance at Dec. 31, 2024         $ 137     $ 53,027,049 (47,169,206) $ 5,702         5,863,682
Beginning balance (in shares) at Dec. 31, 2024         1,357,165                    
Stockholders' Equity                              
Stock based compensation         $ 7     585,816             585,823
Stock based compensation (in shares)         73,971                    
Exercise of investor warrants         $ 16     484,310             484,326
Exercise of investor warrants (in shares)         162,008                    
Issuance of Series D preferred stock and warrants         $ 3     109,113             109,116
Preferred stock dividends                 (97,169)           (97,169)
Deemed dividends on preferred stock $ 106,973               (106,973)           (106,973)
Issuance of common stock for consulting fees               724,230             724,230
Issuance of common stock for consulting fees (in shares)         34,517                    
Issuance of warrants for consulting fees       $ 105,341     $ 157,442             $ 157,442  
Preferred stock accretion 3,407,659             (3,732,454)             (3,732,454)
Modification of Series C Preferred Stock 343,282         $ 6,017,668         $ 6,017,668        
Reclassification of warrants upon amendment               21,426,648             21,426,648
Net loss                 (17,130,909)           (17,130,909)
Balance, Ending at Jun. 30, 2025 267,711       $ 251     81,747,969 (64,504,257) 5,702         17,249,665
Balance, Ending (in shares) at Jun. 30, 2025         2,504,911                    
Beginning balance at Dec. 31, 2024 $ 912,830                            
Beginning balance (in shares) at Dec. 31, 2024 4,285                            
Temporary Equity                              
Preferred stock redemptions and conversions $ (4,583,396)                            
Preferred stock redemptions and conversions (in shares) (4,062)                            
Ending balance at Dec. 31, 2025   $ 507,927 $ 338,774                 $ 507,927 $ 338,774    
Ending balance (in shares) at Dec. 31, 2025   679 11,000                 679 11,000    
Beginning balance at Dec. 31, 2024         $ 137     53,027,049 (47,169,206) 5,702         5,863,682
Beginning balance (in shares) at Dec. 31, 2024         1,357,165                    
Stockholders' Equity                              
Preferred stock redemptions and conversions         $ 88     2,948,147             2,948,235
Preferred stock redemptions and conversions (in shares)         877,250                    
Balance, Ending at Dec. 31, 2025         $ 746     97,242,028 (76,196,995) 5,702         21,051,481
Balance, Ending (in shares) at Dec. 31, 2025         7,448,343                    
Beginning balance at Mar. 31, 2025 $ 1,278,855                            
Beginning balance (in shares) at Mar. 31, 2025 3,570                            
Temporary Equity                              
Issuance of preferred stock and warrants       $ 105,341                      
Issuance of preferred stock and warrants (in shares)       5,500                      
Deemed dividends on preferred stock $ 53,174               (53,174)           (53,174)
Preferred stock redemptions and conversions $ (3,761,034)                            
Preferred stock redemptions and conversions (in shares) (3,347)                            
Preferred stock accretion $ 2,320,675                            
Preferred stock dividends 32,759 $ 16,806             (49,565)           (49,565)
Modification of Series C Preferred Stock 343,282                            
Ending balance at Jun. 30, 2025 $ 267,711 $ 446,942                          
Ending balance (in shares) at Jun. 30, 2025 223 5,500                          
Beginning balance at Mar. 31, 2025         $ 140     52,048,387 (46,885,440) 5,702         5,168,789
Beginning balance (in shares) at Mar. 31, 2025         1,389,815                    
Stockholders' Equity                              
Stock based compensation         $ 7     582,107             582,114
Stock based compensation (in shares)         73,971                    
Exercise of investor warrants         $ 16     484,310             484,326
Exercise of investor warrants (in shares)         162,008                    
Issuance of Series D preferred stock and warrants             $ 157,442             $ 157,442  
Preferred stock dividends $ 32,759 $ 16,806             (49,565)           (49,565)
Preferred stock redemptions and conversions         $ 88     2,948,147             2,948,235
Preferred stock redemptions and conversions (in shares)         877,250                    
Deemed dividends on preferred stock 53,174               (53,174)           (53,174)
Issuance of common stock for consulting fees               4,500             4,500
Issuance of common stock for consulting fees (in shares)         1,867                    
Issuance of warrants for consulting fees               724,230             724,230
Preferred stock accretion   324,795           (2,645,470)             (2,645,470)
Modification of Series C Preferred Stock           $ 6,017,668         $ 6,017,668        
Reclassification of warrants upon amendment               21,426,648             21,426,648
Net loss                 (17,516,078)           (17,516,078)
Balance, Ending at Jun. 30, 2025 $ 267,711       $ 251     81,747,969 (64,504,257) 5,702         17,249,665
Balance, Ending (in shares) at Jun. 30, 2025         2,504,911                    
Beginning balance at Dec. 31, 2025   $ 507,927 $ 338,774                 $ 507,927 $ 338,774    
Beginning balance (in shares) at Dec. 31, 2025   679 11,000                 679 11,000    
Temporary Equity                              
Preferred stock accretion   $ 184,630 $ 3,680,298                        
Accrual of preferred stock dividends   17,090 387,339                        
Preferred stock dividends   (23,621) (547,756)                        
Ending balance at Jun. 30, 2026   $ 686,026 $ 3,858,655                 $ 686,026 $ 3,858,655    
Ending balance (in shares) at Jun. 30, 2026   679 11,000                 679 11,000    
Beginning balance at Dec. 31, 2025         $ 746     97,242,028 (76,196,995) 5,702         21,051,481
Beginning balance (in shares) at Dec. 31, 2025         7,448,343                    
Stockholders' Equity                              
Stock based compensation               318,325             318,325
Preferred stock dividends   $ (23,621) $ (547,756)                        
Issuance of common stock for consulting fees         $ 2     108,952             108,954
Issuance of common stock for consulting fees (in shares)         24,769                    
Issuance of warrants for consulting fees               584,487             584,487
Preferred stock accretion               (3,864,928)             (3,864,928)
Accrual of preferred stock dividends                 (404,429)           (404,429)
Net loss                 (5,044,574)           (5,044,574)
Balance, Ending at Jun. 30, 2026         $ 748     94,388,864 (81,645,998) 5,702         12,749,316
Balance, Ending (in shares) at Jun. 30, 2026         7,473,112                    
Beginning balance at Mar. 31, 2026   $ 694,852 $ 2,211,006                        
Beginning balance (in shares) at Mar. 31, 2026   679 11,000                        
Temporary Equity                              
Accrual of preferred stock dividends   $ 8,545 $ 192,500                        
Preferred stock dividends   (17,371) (385,000)                        
Ending balance at Jun. 30, 2026   $ 686,026 $ 3,858,655                 $ 686,026 $ 3,858,655    
Ending balance (in shares) at Jun. 30, 2026   679 11,000                 679 11,000    
Beginning balance at Mar. 31, 2026         $ 748     95,398,301 (72,145,987) 5,702         23,258,764
Beginning balance (in shares) at Mar. 31, 2026         7,471,931                    
Stockholders' Equity                              
Stock based compensation               241,725             241,725
Preferred stock dividends   $ (17,371) $ (385,000)                        
Issuance of common stock for consulting fees               4,500             4,500
Issuance of common stock for consulting fees (in shares)         1,181                    
Issuance of warrants for consulting fees               584,487             584,487
Preferred stock accretion     $ 1,840,149         (1,840,149)             (1,840,149)
Accrual of preferred stock dividends                 (201,045)           (201,045)
Net loss                 (9,298,966)           (9,298,966)
Balance, Ending at Jun. 30, 2026         $ 748     $ 94,388,864 $ (81,645,998) $ 5,702         $ 12,749,316
Balance, Ending (in shares) at Jun. 30, 2026         7,473,112